Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05759572
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2023-02-26
Brief Title:
Apatinib With CDK46 Inhibitor and Endocrine Therapy in HR HER2- Advanced Breast Cancer
Sponsor:
Fudan University
Organization:
Fudan University
Organization Data
Organization:
Fudan University
Class:
OTHER
Study ID:
BCTOP-L-M04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fudan University
Lead Sponsor Class:
OTHER
Responsible Party:
Zhimin Shao
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fudan University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Peking University Cancer Hospital Institute | OTHER |
| First Hospital of China Medical University | OTHER |
| Sun Yat-sen University | OTHER |
| First Affiliated Hospital Xian Jiaotong University | OTHER |
| Liaoning Tumor Hospital Institute | OTHER |
| Chongqing University Cancer Hospital | OTHER |
| Northern Jiangsu Peoples Hospital | OTHER |
| Fujian Medical University Union Hospital | OTHER |
| Ningbo Medical Center Lihuili Hospital | OTHER_GOV |
| Shanghai First Maternity and Infant Hospital | OTHER |
| Shanghai 6th Peoples Hospital | OTHER |
| Affiliated Hospital of Nantong University | OTHER |